India News | NIAB Hyderabad Notified as Central Drugs Lab for Testing, Batch Release of Vaccines
Get latest articles and stories on India at LatestLY. The National Institute of Animal Biotechnology (NIAB) has been upgraded as Central Drugs Laboratory for Covid vaccine testing facility at Hyderabad, the Department of Biotechnology said on Saturday.
New Delhi, Aug 21 (PTI) The National Institute of Animal Biotechnology (NIAB) has been upgraded as Central Drugs Laboratory for Covid vaccine testing facility at Hyderabad, the Department of Biotechnology said on Saturday.
Also Read | Uttarakhand Shocker: Youth Kills 19-Year-Old Girl, Later Ends Life By Consuming Poison in Almora.
The DBT said the Centre has identified NIAB, Hyderabad and National Centre for Cell Science (NCCS), Pune, for upgrading as central drug laboratories.
Also Read | Taliban Maligning Islam Through Terror Activities: Ajmer Dargah Spiritual Head Syed Jainul Abedin.
"With support from PM CARES funds, the laboratory of the National Institute of animal Biotechnology (NIAB), has been upgraded as Central Drugs Laboratory (CDL) for COVID-19 vaccine testing facility at Hyderabad.
"The facility at NIAB, Hyderabad, has now been notified as Central Drugs Laboratory for testing and release of COVID-19 vaccines vide. Gazette notification issued by the Ministry of Health & Family Welfare on August 17," the DBT said.
The facility at the NCCS, Pune has already been notified as Central Drugs Laboratory on June 28.
The two facilities are expected to test approximately 60 batches of vaccines per month.
Considering that the facilities are located in proximity to the country's vaccine manufacturing hubs Pune and Hyderabad, logistics for vaccine manufacturing and supply are expected to be eased up.
"The generous support through PM-CARES Funds and the relentless efforts of the two institutes enabled the rapid up-gradation and setting up of the state-of-the-art, modern GLP compliant vaccine testing facilities and contribute to the national requirement. This would further strengthen the vaccine supply chain and boost the massive vaccination drive in India," the DBT added.
(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)